Search clinical trials for: LCL161
Total 13 results
-
Novartis PharmaceuticalsCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Novartis PharmaceuticalsCompletedPrimary Myelofibrosis | Secondary Myelofibrosis | Polycythemia Vera, Post-Polycythemic Myelofibrosis PhaseUnited States
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedMultiple MyelomaUnited States, Italy, Spain, Germany
-
Novartis PharmaceuticalsCompletedA Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid TumorsSolid TumorsSpain, Italy, United States, Canada
-
Novartis PharmaceuticalsCompletedBreast CancerSpain, United Kingdom, Taiwan, Australia, Russian Federation, Germany, Korea, Republic of, Ireland, United States, Italy, Brazil, Czech Republic
-
Pierre Fabre MedicamentCompletedDrug-induced XerostomiaGermany
-
SCRI Development Innovations, LLCNovartis PharmaceuticalsTerminatedSmall Cell Lung Cancer | Ovarian CancerUnited States
-
UNICANCERActive, not recruiting
-
BayerCompletedContraceptionSweden, United States, France, Hungary, Netherlands, Chile, Canada, Finland, Mexico, Argentina, Norway
-
US Oncology ResearchNovartis Pharmaceuticals; Delta Clinical Research, LLCUnknownMetastatic Pancreatic CancerUnited States
-
Novartis PharmaceuticalsCompletedColorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell CarcinomaUnited States, Spain, Taiwan, Germany, Netherlands, United Kingdom, Korea, Republic of
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States